# Bristol-Myers Squibb (BMY) — Overview

BMY · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/bmy

## Price

Last close $60.84 on Oct 16, 2026. 52-week range $42.60 – $68.09.

## Company profile

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $49.2B |
| Revenue (quarter) | $13.0B |
| Revenue growth (year over year) | 5.74% |
| Gross profit (trailing twelve months) | $34.5B |
| Gross margin | 70.16% |
| Net income (trailing twelve months) | $9.3B |
| Net income (quarter) | $3.3B |
| Net income growth (year over year) | 152.55% |
| Net margin | 18.85% |
| Return on equity | 46.70% |
| EPS (trailing twelve months) | $4.56 |
| Book value per share | $10.92 |
| P/E (trailing twelve months) | 13.4 |
| Price to book | 5.6 |
| Debt to assets | 74.53% |
| Payout ratio | 71.29% |
| Dividend yield | 4.13% |

## Frequently Asked Questions

### Is Bristol-Myers Squibb (BMY) profitable?

Yes. Bristol-Myers Squibb earned $9.3B in net income over the trailing twelve months, a net margin of 18.85%.

### How much revenue does Bristol-Myers Squibb (BMY) make?

Bristol-Myers Squibb generated $49.2B in revenue over the trailing twelve months, up 5.74% year over year.

### What is BMY's P/E ratio?

Bristol-Myers Squibb trades at 13.4 times trailing twelve-month earnings, on an EPS of $4.56.

### How do I buy stock in Bristol-Myers Squibb (BMY)?

BMY trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

## Similar Stocks

- [MRK](https://www.lighthorse.io/tickers/mrk) — Merck & Company, Inc. Common Stock (new)
- [PFE](https://www.lighthorse.io/tickers/pfe) — Pfizer, Inc. Common Stock
- [JNJ](https://www.lighthorse.io/tickers/jnj) — Johnson & Johnson Common Stock
- [ABBV](https://www.lighthorse.io/tickers/abbv) — AbbVie Inc. Common Stock
- [AMGN](https://www.lighthorse.io/tickers/amgn) — Amgen Inc. - Common Stock
- [LLY](https://www.lighthorse.io/tickers/lly) — Eli Lilly and Company Common Stock
- [GILD](https://www.lighthorse.io/tickers/gild) — Gilead Sciences, Inc. - Common Stock
- [EXEL](https://www.lighthorse.io/tickers/exel) — Exelixis, Inc. - Common Stock
- [VRTX](https://www.lighthorse.io/tickers/vrtx) — Vertex Pharmaceuticals Incorporated - Common Stock
- [AZN](https://www.lighthorse.io/tickers/azn) — AstraZeneca PLC Ordinary Shares

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).